Nov 9 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
Hosted on MSN
COVID-19 vaccines: Get the facts
Find out about the different types of coronavirus disease 2019 (COVID-19) vaccines, how they work, the possible side effects, and the benefits for you and your family. What are the benefits of getting ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...
This year’s updated COVID-19 vaccines have been approved by the U.S. Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback